¼±Åà - È­»ìǥŰ/¿£ÅÍŰ ´Ý±â - ESC

 
"Fanconi Anemia Complementation Group Proteins"¿¡ ´ëÇÑ °Ë»ö °á°úÀÔ´Ï´Ù. °Ë»ö °á°ú º¸´Â µµÁß¿¡ Tab ۸¦ ´©¸£½Ã¸é °Ë»ö âÀÌ ¼±Åõ˴ϴÙ.
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
  • fetal anemia
    žƺóÇ÷
  • folate deficiency anemia
    ¿±»ê°áÇ̺óÇ÷
  • hyperchromic anemia
    °í»ö¼ÒºóÇ÷
  • hypochromic anemia
    Àú»ö¼ÒºóÇ÷
  • hypoplastic anemia
    ÀúÇü¼ººóÇ÷
  • Heinz body hemolytic anemia
    ÇÏÀÎÃ÷¼Òü¿ëÇ÷ºóÇ÷
  • hemolytic anemia
    ¿ëÇ÷ºóÇ÷
  • iron deficiency anemia
    ö°áÇ̺óÇ÷
  • isoimmune hemolytic anemia
    µ¿Á¾¸é¿ª¿ëÇ÷ºóÇ÷
  • immunohemolytic anemia
    ¸é¿ª¿ëÇ÷ºóÇ÷
  • idiopathic anemia
    Ư¹ßºóÇ÷
  • leukoerythroblastic anemia
    ¹éÀûÇ÷¸ð±¸ºóÇ÷
  • lactation anemia
    ¼öÀ¯ºóÇ÷
  • miner¡¯s anemia
    ±¤ºÎºóÇ÷
  • malignant anemia
    ¾Ç¼ººóÇ÷
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
  • group-specific antigen
    ±ºÆ¯ÀÌÇ׿ø
  • basic food group
    ±âÃʽÄǰ±º
  • blood group
    Ç÷¾×Çü
  • blood group incompatibility
    Ç÷¾×ÇüºÎÀûÇÕ
  • blood group system
    Ç÷¾×Çü±º
  • blood group specific substance
    Ç÷¾×ÇüƯÀ̹°Áú
  • borderline group
    °æ°è±º
  • coliform group
    ´ëÀå±Õ±º
  • complementophil group
    º¸Ã¼Ä£È­±â
  • control group
    ´ëÁ¶±º
  • determinant group
    °áÁ¤±º
  • diagnosis related group
    À¯»çÁø´Ü±ºÀÇ·áºñÁöºÒ¹ý
  • didactic group therapy
    ±³À°Áý´Ü¿ä¹ý
  • directive group therapy
    Áö½ÃÁý´Ü¿ä¹ý
  • group dynamics
    Áý´Ü¿ªÇÐ, Áý´Ü¿ªµ¿
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
  • group-specific antigen
    ±ºÆ¯ÀÌÇ׿ø
  • group-specific antigen
    ±º-ƯÀÌÇ׿ø
  • haptenic group
    ÇÕÅÙ±â(¡­Ðñ).
  • hearing aid, group
    Áý´Üº¸Ã»±â
  • high risk group
    °íÀ§Çèµµ±º(Ë­Ëô̴̬˴).
  • hydroxyl group
    ÇÏÀ̵å·Ï½Ç±â(¡­Ðñ).
  • incompatibility group, plasmid
    ÇÃ¶ó½º¹Ìµå ºñÀûÇÕ±º
  • indeterminate group
    ¹ÌÁ¤Çü±º(Ú±ïÒúþÏØ).
  • indeterminate group
    ¹ÌÁ¤Çü±º(ËÑËøÌ´Ë´).
  • posterior group of aphasia
    ÈĺνǾ(ý­Ý»ã÷åÞÏØ).
  • posterior group of aphasia
    ÈĺνǾ(ý­Ý»ã÷åÞÏØ)
  • prepaid group practice
    ¼±ºÒÁ¦Áý´Ü°³¿ø.
  • prostheitc group
    ¹èÇÕ±º(ÛÕùêÏØ).
  • prosthetic group-labeled enzyme
    º¸Á¶±ºÇ¥ÁöÈ¿¼Ò
  • prosthetic group-labeled immunoassay
    º¸Á¶±ºÇ¥Áö¸é¿ªÃøÁ¤(¹ý)
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
  • group Ia inhibition
    ¥°a¤ÇϹA.
  • group antigen
    ±ºÇ׿ø(ÏØù÷ê«).
  • group audiometry
    Áý´Üû·Â°Ë»ç(¹ý)
  • group conformity rating =GCR
    Áý´ÜÇÕÄ¡ µî±ÞºÐ·ù(ÊṴ̬̀ËÄË»ËÓËÈ).
  • group discussion
    Áý´ÜÅäÀÇ(̤ËÀ̬Ëö).
  • group displacement law
    Áý´Üº¯À§¹ýÄ¢(ÊÙËÒ ËôËÑ̬).
  • group dynamics
    Áý´Ü¿ªÇÐ(ÊÙËç ).
  • group file
    ±×·ì È­ÀÏ
  • group hearing aid
    Áý´Üº¸Ã»±â
  • group hospital
    º´¿øÁ¶ÇÕ(ËÓËô̡̰).
  • group incompatibility
    Ç÷¾×±ººÎÀûÇÕ(úìäûÏØ ÝÕîêùê).
  • group medicine
    Áý´Ü<Çùµ¿>Áø·á.
  • group of isogenous chondrocyte
    ¿¬°ñ¼¼Æ÷¹«¸®
  • group of muscles
    ±ÙÀ°¹«¸®, ±Ù±º(ÐÉÏØ).
  • group of muscles
    ±ÙÀ°¹«¸®, ±Ù__ÐÉÏØ).
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
  • formyl group
    Æ÷¸£¹Ð±â(Ðñ)
  • functional group
    ÀÛ¿ë±â(íÂéÄÐñ)
  • functional group isomer
    ÀÛ¿ë±â(íÂéÄÐñ) À̼ºÃ¼(ì¶àõô÷)
  • glucosyl group
    ±Û·çÄڽDZâ(Ðñ)
  • glycoaldehyde group
    ±Û¶óÀÌÄھ˵¥ÇÏÀ̵å±â(Ðñ)
  • glycolaldehyde group
    ±Û¶óÀÌÄݾ˵¥ÇÏÀ̵å±â(Ðñ)
  • glycoloyl group
    ±Û¶óÀÌÄÚ·ÎÀϱâ(Ðñ)
  • glycolyl group
    ±Û¶óÀÌÄÚ¸±±â(Ðñ)
  • glycosyl group
    ±Û¶óÀÌÄڽDZâ(Ðñ)
  • Gm group
    Gm ±â(Ðñ)
  • group specificity
    ±â(Ðñ) ƯÀ̼º(÷åì¶àõ)
  • group transfer reaction
    ¿øÀÚ´Ü ÀüÀÌ ¹ÝÀÀ(ê«í­Ó¥ï®ì¹Úãëë)
  • group transfer potential
    ¿øÀÚ´Ü ÀüÀÌ ÀüÀ§(ê«í­Ó¥ï®ì¹Úãëë)
  • group translocation
    ¹«¸® ÀüÀ§(ï®êÈ)
  • guanidinium group
    ±¸¾Æ´Ïµð´Ï¿ò±â(Ðñ)
KMLE ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 5
GS gallstone; Gardner syndrome; gastric shield; general surgery; gestational score; Gilbert syndrome; g...
GT gait training; galactosyl transferase; gastrostomy; generation time; genetic therapy; gingiva treatm...
MN a blood group in the MNSs blood group system; malignant nephrosclerosis; Master of Nursing; meganewt...
ACD   1) Absolute Cardiac Dullness; Àý´ë½ÉµÐŹÀ½
  2) Anemia of Chronic Disease
&nbs...
AHA Autoimmune Hemolytic Anemia
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 5
group II group I
Group III group
AISA Acquired Idiopathic Sideroblastic Anemia
ACD Anemia of chronic disorders
AA Aplastic Anemia
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü À¯»ç °Ë»ö °á°ú : 11 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
  • poikilocytic anemia
    º¯Çü ÀûÇ÷±¸¼º ºóÇ÷, ÀÌÇü ÀûÇ÷±¸¼º ºóÇ÷
  • secondary anemia
    ¼Ó¹ß¼º ºóÇ÷
  • sickle cell anemia
    °â»ó ÀûÇ÷±¸ ºóÇ÷
    À¯Àü¼ºÀÇ ¿ëÇ÷¼º ºóÇ÷·Î¼­ ÀÌ»ó Ç÷»ö¼ÒÁõÀÇ ÇϳªÀ̸ç ÈæÀο¡°Ô¼­ ÁÖ·Î ³ªÅ¸³ª°í Ç÷¾×¿¡ °â»ó ÀûÇ÷±¸°¡ ÀÖ´Â °ÍÀÌ Æ¯Â¡ÀÌ´Ù.
  • sickle-cell anemia
    °â»ó ÀûÇ÷±¸ ºóÇ÷
    À¯ÀüÀûÀ¸·Î Çì¸ð±Û·Îºó º£Å¸ ±Û·Îºó chainÀÌ valineÀ¸·Î ¹Ù²î¾î ³´ ¸ð¾çÀÇ ÀûÇ÷±¸¸¦ »ý¼ºÇÏ´Â »óÅÂ. ÈæÀο¡°Ô¼­ ¸¹ÀÌ ¹ß»ýÇÑ´Ù.
  • sideroblastic refractory anemia
    ö Àû¸ð±¸¼º ºÒÀÀ¼º ºóÇ÷
  • sideropenic anemia
    ö °áÇ̼º ºóÇ÷
    µ¿ÀǾî=iron deficiency anemia. 1. Ç÷ÀåÀÇ Ã¶ºÐÀÌ Àú³óµµÀÎ °ÍÀ» Ư¡À¸·Î ÇÏ´Â ºóÇ÷, ö °áÇ̼º ºóÇ÷°ú ¸¸¼º ºóÇ÷µµ Æ÷ÇÔÇÑ´Ù. 2. ö °áÇ̼º ºóÇ÷Àº °¡Àå ÈçÇÑ Áúȯ Áß Çϳª·Î ¿ù°æ ÃâÇ÷·Î ÀÎÇØ ÀþÀº ¿©¼ºµé¿¡¼­ ÁÖ·Î °üÂûµÈ´Ù. ºóÇ÷Àº Á¶Á÷ ³» »ê¼Ò °ø±ÞÀÇ ºÎÁ·À» ÃÊ·¡Çϸç, ö °áÇ̼º ºóÇ÷À̶õ ¿©·¯ ¿øÀο¡ ÀÇÇØ ü³» ÀúÀå öÀÌ ÇÊ¿äÇÑ ¾çº¸´Ù ºÎÁ·ÇÏ¿© ÀûÇ÷±¸ »ý¼º¿¡ Àå¾Ö°¡ ¹ß»ýÇÏ¿© ÃÊ·¡µÈ´Ù. ¿øÀÎÀ¸·Î´Â °í±â µî öºÐÀÌ µé¾îÀÖ´Â À½½ÄÀÇ ¼·Ãë ºÎÁ·À̳ª À§ ÀýÁ¦¼úÀ» ¹ÞÀº °æ¿ì À§»êÀÇ ºÎÁ·À¸·Î ö Èí¼ö°¡ ºÎÁ·ÇÑ °æ¿ì, ¼ºÀå±â ¾î¸°ÀÌ¿Í Ã»¼Ò³â µî üÁß Áõ°¡¿¡ µû¸¥ ¿ä±¸·®ÀÇ Áõ°¡, ÀӽŠÁßÀÇ ¿©¼º¿¡¼­ žƿ¡ °ø±Þ, ÅÂ¹Ý ¹× Ãâ»ê ½ÃÀÇ ÃâÇ÷, »ý¸®Àû ÀûÇ÷±¸ÀÇ ÃÑ·® Áõ°¡ µîÀÇ ÀÌÀ¯·Î öºÐÀÇ ¿ä±¸·®ÀÌ Áõ°¡ÇÑ´Ù. À§ ±Ë¾ç, Ä¡Áú, Á¾¾ç µî ¸¸¼ºÀûÀÎ À§ Àå°ü ÃâÇ÷À̳ª ¿ù°æ µîÀÇ ¸¸¼ºÀûÀÎ ÃâÇ÷·Î ö ¼Õ½ÇÀÌ Áõ°¡µÇ´Â °æ¿ì ö °áÇ̼º ºóÇ÷ÀÌ ÃÊ·¡µÈ´Ù. Áõ»óÀº ÇǺΰ¡ â¹éÇϸç ź·ÂÀÌ ¼Ò½ÇµÇ°í ¼Õ±ÝÀÇ ÇÎÅ©»öÀÌ ¼Ò½ÇµÇ±âµµ ÇÑ´Ù. ¼ÕÅé¿¡ ±¤ÅÃÀÌ ¼Ò½ÇµÇ°í ºÎ¼­Áö±â ½¬¿ì¸ç ¿À¸ñÇÏ°Ô º¯ÇüµÈ´Ù. ÇÇ·Î, µÎÅë, Çö±âÁõ, ½Ç½Å, ±Ù·ÂÀÇ ÀúÇÏ, ºÒ¾È, È£Èí °ï¶õ, ºó¸Æ, ºÎÁ¾ µîÀ» ÃÊ·¡Çϱ⵵ ÇÑ´Ù. ¶ÇÇÑ ½Ä¿å ºÎÁø, ±¸Åä, º¹ºÎ ºÒÄè°¨, º¯ºñ, ¼³»ç¸¦ ÃÊ·¡ÇÒ ¼öµµ ÀÖ´Ù. °Ë»ç´Â ±âº» °Ë»ç·Î Ç÷»ö¼Ò¿Í Ç츶ÅäÅ©¸´, ¸Á»ó±¸, ¸»ÃÊÇ÷¾× µµ¸» °Ë»ç, Ç÷Áß Ã¶ ¹× ö °áÇÕ´É, ÀúÀå öÀ» ¹Ý¿µÇÏ´Â ÈѸ®Æ¾, ´ëº¯ÀáÇ÷ ¹ÝÀÀ°Ë»ç µîÀÌ ÀÖ´Ù. ƯÈ÷ ö °áÇÌÀº Çö»óÀ̹ǷΠ±Ùº»ÀûÀÎ ¿øÀÎÀÇ Á¦°Å°¡ ÇÊ¿äÇѵ¥ ¿ù°æ·Â¿¡ ´ëÇÑ ÀÚ¼¼ÇÑ ¹®ÁøÀÌ ÇÊ¿äÇÏ´Ù. ³²ÀÚ¿¡¼­ ö °áÇ̼º ºóÇ÷ÀÌ ³ªÅ¸³ª°Å³ª ȤÀº ¿©ÀÚ¿¡¼­µµ 40¼¼ À̻󿡼­ ³ªÅ¸³ª´Â °æ¿ì´Â À§ ³»½Ã°æÀ» ºñ·ÔÇÑ À§ Àå°ü °Ë»ç°¡ ÇÊ¿äÇÏ´Ù. ±× Ä¡·á´Â ö °áÇ̼º ºóÇ÷À» ÃÊ·¡ÇÑ ¿øÀÎÀ» ¹àÇô³»°í À̸¦ Ä¡·áÇØ¾ß Çϸç, ºóÇ÷À» ±³Á¤ÇÏ°í ºÎÁ·ÇÑ Ã¼³» ÀúÀå öÀ» ÃæÁ·½ÃÄÑ¾ß ÇÑ´Ù. ºÎÀûÀýÇÑ ½Ä»ç°¡ ¿øÀÎÀ̶ó¸é À̸¦ ±³Á¤ÇÏ°í ±ÕÇüµÈ ½Ä»ç¸¦ Çϵµ·Ï ÇÑ´Ù. ±×·¯³ª ½ÄÀÌ ¿ä¹ý ´Üµ¶À¸·Î ö °áÇ̼º ºóÇ÷ÀÌ ±³Á¤µÇÁö´Â ¾Ê´Â´Ù. °æ±¸¿ë öºÐ Á¦Á¦°¡ ¸¹ÀÌ ÀÖÀ¸³ª ºñŸ¹Î ¾¾¸¦ ÇÔÀ¯ÇÑ Á¦Á¦´Â Èí¼öÀ² Áõ°¡ÀÇ È¿°ú¿¡ ºñÇØ °¡°ÝÀÌ ºñ½Î°í À§Àå Àå¾Ö¸¦ ÁÙÀ̱â À§ÇÑ Àå¿ëÁ¤Àº Èí¼öÀ²ÀÌ ³·´Ù. Ä¡·á ±â°£Àº Ç÷»ö¼Ò°¡ Á¤»óÈ­ÇÑ ÈÄ ¾à 6°³¿ù ÀÌ»ó ´õ º¹¿ëÇØ¾ß ü³» ÀúÀå öÀ» ÃæÁ·½Ãų ¼ö ÀÖ´Ù. ö °áÇ̼º ºóÇ÷Àº ¸Å¿ì ÈçÇÑ ÁúȯÀ̸ç Ä¡·á°¡ ÀÚÁÖ ½ÇÆÐÇÏ´Â ÁúȯÀ¸·Î ±× ÁÖµÈ ½ÇÆÐ ¿øÀÎÀº ÃæºÐÇÑ ±â°£µ¿¾È öºÐ Á¦Á¦¸¦ º¹¿ëÇÏÁö ¾Ê´Âµ¥ ÀÖ´Ù.
  • splenic anemia
    ºñ¼º ºóÇ÷
  • symptomatic anemia
    ÁõÈļº ºóÇ÷
  • traumatic hemolytic anemia
    ¿Ü»ó¼º ¿ëÇ÷¼º ºóÇ÷
  • warm-antibody autoimmune hemolytic anemia
    ¿Â³­ Ç×ü ÀÚ°¡¸é¿ª¼º ¿ëÇ÷¼º ºóÇ÷
  • warm-reacting autoimmune hemolytic anemia
    »ó¿Â ¹ÝÀÀ¼º ÀÚ°¡ ¸é¿ª¼º ¿ëÇ÷¼º ºóÇ÷, ¿ÂÇ×ü¿¡ ÀÇÇÑ ¿ëÇ÷
    »ó¿Â ¹ÝÀÀ¼º Ç×ü
CancerWEB ¿µ¿µ ÀÇÇлçÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 5
growth associated proteins <growth factor> Group of developmentally regulated polypeptides thought to be critical for the formation of neural circuitry. The acidic membrane phosphoprotein GAP 43 is synthesised and transported down regenerating and developing axons, pp46 localised in growth cone membranes during embryogenesis, B 50 in mature presynaptic membranes in the regulation of phosphotidylinositol turnover and F1 in the hippocampus during long-term potentiation, are now all known to be the same protein.
(18 Nov 1997)
RNA-binding proteins Proteins which bind to RNA molecules. Certain structure motifs are common to several of the proteins, such as arginine (arg)-rich tracts, typically consisting of alternating arg-asp, arg-ser, or arg-gly residues. These proteins also tend to have a common ribonucleotide sequence domain.
(12 Dec 1998)
cholesterol ester transport proteins A protein that transports cholesterol esters from HDL to VLDL and LDL; a deficiency of this protein is associated with elevated HDL cholesterol.
(05 Mar 2000)
chromosomal proteins, non-histone Nucleoproteins which in contrast to histones are acid insoluble. They are involved in chromosomal functions; e.g. They bind selectively to DNA, stimulate transcription resulting in tissue-specific RNA synthesis and undergo specific changes in response to various hormones or phytomitogens.
(12 Dec 1998)
microfilament proteins Filaments which are composed primarily of actin and found in the cytoplasmic matrix of almost all cells. They are often associated with microtubules and may play a role in cytoskeletal function and/or mediate movement of the cell or the organelles within the cell.
(12 Dec 1998)
microtubule-associated proteins <protein> High molecular weight proteins found in the microtubules of the cytoskeletal system. Under certain conditions they are required for tubulin assembly into the microtubules and stabilise the assembled microtubules.
Acronym: MAP
(12 Dec 1998)
milk proteins The major protein constituents of milk are caseins and whey proteins such as lactalbumin and lactoglobulins. Immunoglobulins occur in high concentrations in colostrum and in relatively lower concentrations in milk.
(12 Dec 1998)
phosphorylation of proteins <biochemistry> Addition of phosphate groups to hydroxyl groups on proteins (side chains s, T or Y) catalysed by a protein kinase often specific) with ATP as phosphate donor. Activity of proteins is often regulated by phosphorylation.
(18 Nov 1997)
clathrin adaptor proteins <cell biology> Family of proteins that bind to clathrin and promote its assembly into vesicle coats. Different adaptor proteins are associated with coated vesicles of Golgi or plasma membrane origin.
(18 Nov 1997)
monocyte chemoattractant proteins Chemokines that are chemoattractants for monocytes. These cc chemokines (cysteines adjacent) number at least three including monocyte chemoattractant protein-1.
(12 Dec 1998)
monosaccharide transport proteins Membrane transport proteins which bind glucose and sodium ions and enter the cell together. The sodium ions are then pumped out of the cell by a sodium potassium atpase. The rate and extent of the sugar transport depends on the sodium ion concentration. Inhibitors of the monosaccharide transport system are phlorizin, cytochalasin b, and inhibitors of the sodium potassium atpase system. Insulin increases the rate of monosaccharide transport across the membrane into the cell.
(12 Dec 1998)
plant proteins Proteins found in plants (flowers, herbs, shrubs, trees, etc.). The concept does not include proteins found in vegetables for which vegetable proteins is available.
(12 Dec 1998)
m proteins Antibodies or parts of antibodies found in unusually large amounts in the blood or urine of multiple myeloma patients.
(12 Dec 1998)
plasma proteins Dissolved protein's (more than 100) of blood plasma, mainly albumins and globulins (normally 6 to 8 g/100 ml); they hold fluid in blood vessels by osmosis and include antibodies and blood-clotting protein's.
Synonym: serum proteins.
(05 Mar 2000)
muscle proteins The protein constituents of muscle, the major ones being actins and myosin. More than a dozen accessary proteins exist including troponin, tropomyosin, and dystrophin.
(12 Dec 1998)
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
KMLE ¾àǰ/ÀǾàǰ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
KMLE ¾àǰ/ÀǾàǰ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
KMLE ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
ÀÇÇÐ³í¹® ¾àÀÚ(Pubmed/Entrez) °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
CancerWEB ¿µ¿µ ÀÇÇлçÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
MeSH(Medical Subject Headings) ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 5
MeSH(Medical Subject Headings) À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 5
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü ¸ÂÃã °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 5
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü À¯»ç °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 5
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 5
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 5
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 5
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 5
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ ¸ÂÃã °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 5
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ À¯»ç °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 5
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference ¸ÂÃã °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 5
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference À¯»ç °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 5
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition ¸ÂÃã °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 5
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition À¯»ç °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 5
KMLE À¥ ¿ë¾î ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
KMLE À¥ ¿ë¾î À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
ÇÑ¿µ/¿µÇÑ »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
ÇÑ¿µ/¿µÇÑ »çÀü À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
WordNet ÀÏ¹Ý ¿µ¿µ »çÀü °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü ¸ÂÃã °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 5
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü À¯»ç °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 5
ÅëÇÕ°Ë»ö ¿Ï·á